Alcohol, Tobacco, and Other Drugs

Submit Abstract

Call for Abstracts for the 2006 Annual Meeting

Each year, members of the ATOD Section have the opportunity to present papers and research results during the Annual Meeting of the American Public Health Association. The Section typically sponsors over 70 Scientific and Poster Sessions, during which about 500 oral and poster presentations are made. Preparations are being made now for the 2006 Annual Meeting in Boston, MA, November 5-9, 2006. The overall theme of the convention will be “Public Health and Human Rights”, which pertains to numerous topics in our field.

The ATOD section invites abstracts in all areas pertaining to:
  • alcohol

  • tobacco

  • other drugs
    • Important Issues in Tobacco Control Poster Session III
    • **ATOD Waiting List for Oral Presentations
    • **ATOD Waiting List for Poster Presentations
    • AOD
    • AOD and the Chronic Disease Model: Response and Emerging Priorities
    • ATOD - In General
    • ATOD Committee Meeting Place Holder
    • ATOD Late Breaker Session I
    • ATOD Late Breaker Session II
    • ATOD Section Awards Ceremony and Business Meeting
    • ATOD Section Council Meeting I
    • ATOD Section Council Meeting II
    • Adolescent Alcohol Research Poster Session
    • Alcohol
    • Alcohol - Advocacy
    • Alcohol - In General
    • Alcohol - Policy
    • Alcohol - Prevention, I
    • Alcohol - Treatment
    • Alcohol and Other Drugs
    • Broad Look at Screening and Brief Intervention Poster Session
    • Building Capacity for Tobacco Control: Lessons Learned from the States
    • Building Global Tobacco Control
    • Building the Evidence Base for Tobacco Control Policy Interventions in the Era of the Framework Convention on Tobacco Control and Beyond: The International Tobacco Control Policy Evaluation Project
    • Changing Substance Abuse Landscape: Marijuana to Co-Occurring Issues Poster Session
    • Changing World for Tobacco Farmers and Manufacturers
    • Club Drugs
    • Co-Occurring Disorders
    • Co-Occurring Disorders: Epidemiology, Policy, Practice, and Costs
    • Co-Occurring Substance Use and Mental Disorders: Epidemiology, Policy, Practice, and Costs
    • College Students and Tobacco Poster Session
    • Contemporary ATOD Issues: Workplace and the NYC Experience Poster Session
    • Contemporary Issues in Drug Abuse Poster Session
    • Cookbook Solutions for Methamphetamine Challenges
    • Design, Use and Effectiveness of an Interactive Website Addressing Workplace Mental Health, Substance Abuse, and Health Issues
    • Dialogue of Perspectives on Methamphetamine Challenges and Emerging Issues
    • Disparities in Tobacco Control Poster Session
    • Disseminating the Findings of the 2006 Surgeon General's Report: Leveraging Partnerships to Maximize Impact
    • Drinking Patterns, Health and Social Problems: New Results with Public Health Significance from the 2005 National Alcohol Survey
    • Effectiveness of Environmental Alcohol Policies
    • Emerging Information on Tobacco Product Content Poster Session
    • Environmental Approaches to Alcohol Policy Poster Session
    • Environmental Tobacco Smoke Poster Session
    • Etiology and Consequences of Youth and Alcohol
    • Evaluating SmokeLess States to Promote Evidence-Based Policy and Practice
    • Evaluation Update: Substance Abuse Prevention and Treatment
    • Every Breath You Take: Places and Spaces Contaminated by Tobacco Smoke
    • Focusing on Kids: Issues in Tobacco Prevention, Control, and Surveillance Poster Session
    • From Campus to Around the Globe - a Look at Alcohol Poster Session
    • From Injustice to Social Justice: Human Rights in Tobacco Control
    • Getting the Message Out on Tobacco: Mass Media Interventions
    • HELP! Tobacco Quitlines and Cessation Services Poster Session
    • HIV and HCV in Drug Users
    • Healthcare Providers' Roles in Smoking Cessation Efforts Poster Session
    • Helping States and Communities Breathe Easier: Different Perspectives on Passing and Implementing Clean Indoor Air Legislation
    • Human Rights and Substance Abuse Issues
    • Implications of Screening and Brief Intervention: Evidence from Emergency Departments
    • Important Issues in Tobacco Control Poster Session I
    • Important Issues in Tobacco Control Poster Session II
    • Important Issues in Tobacco Control Poster Session IV
    • Improving Hepatitis B Prevention for Drug Injectors through Syringe Exchange Programs
    • Injecting Drug Users
    • Injecting Drug Users: Issues Across Perspectives
    • Injecting Drug Users: Knowledge and Experience Poster Session
    • International ATOD Issues Poster Session
    • International Tobacco Control Issues Poster Session
    • Intervention and Treatment of Alcohol-Related Problems Poster Session
    • Issues in Treating Substance Abuse Poster Session
    • Latino Youth Across America: Patterns of Alcohol Use
    • Making Performance, Evaluation and Cost Data Useful to Feds, States and the Field
    • Marijuana
    • Medicare Part D Workshop
    • Meet the ATOD Leaders Reception
    • Methamphetamine
    • NIH State of the Science on Tobacco Control Policy: What’s New Under the Sun?
    • Performance Evaluation of ATOD Treatment Programs Poster Session
    • Politics, Policy, and Community Action: Best Practices to Combat Underage Drinking
    • Poly-Drug Use and Co-Morbid Conditions Poster Session
    • Prescription Drug Abuse in Young People: Prevalence, Patterns, Factors and Treatment
    • Prevention Standards and Measurement
    • Prevention Strategies: Youth and Young Adults
    • Quit or Die: Cross Cutting Issues in Cessation
    • Recovery and Aftercare
    • Recovery, Spirituality, Relapse, and Recidivism Poster Session
    • Rejected Abstracts
    • SAMHSA's New National Registry of Evidence-Based Programs and Practices
    • Social Marketing as a Cessation Strategy
    • Special Populations Dilemmas in Substance Abuse
    • Special Populations and Substance Abuse Poster Session
    • Special Problems of Special Populations
    • Surveillance of News Media Coverage of Tobacco Issues: Approaches and Findings
    • Systems of Care in Substance Abuse Treatment
    • Systems, Networks, and Tobacco Control Poster Session
    • Taming the Genital Herpes Epidemic: Rethinking the Role of HSV Screening and Testing
    • Tobacco
    • Tobacco - Cessation, I
    • Tobacco - Cessation, II
    • Tobacco - In General, I
    • Tobacco - In General, II
    • Tobacco - In General, III
    • Tobacco - Media
    • Tobacco - Policy, I
    • Tobacco - Policy, II
    • Tobacco - Prevention
    • Tobacco Cessation Poster Session
    • Tobacco Control Policies: Do They Make a Difference for Low Socioeconomic Status Women and Girls?
    • Tobacco Control, Litigation, Regulation, and Policy Poster Session
    • Transdisciplinary Approach to Integrating Primary Care and Behavioral Health
    • Treating Drug Abuse in Vulnerable Populations: A Human Right
    • Treatment Challenges: The Prescription and the Prescriber
    • Understanding Ethnic and Racial Disparities: Alcohol-Related Issues
    • What Would It Take to Dialogue with Big Tobacco?
    • What's Happening in our Communities? Tobacco-Related Health Disparities
    • What's the Tobacco Industry up to Now?
    • Whether on the Street or in the Classroom: Youth Drinking Behaviors and Solutions
    • Women, Family and Children Substance Abuse Issues Poster Session
    • Youth and Adult Partnerships to Reduce Underage Alcohol Problems: Community Involvement in Mobilization, Implementation, and Evaluation
    • xxBuilding Global Tobacco Control
    • xxBuilding the Evidence Base for Tobacco Control Policy: The Interventions in the Era of the Framework Convention on Tobacco Control and Beyond: The International Tobacco Control Policy Evaluation Project
    • xxChanging World for Tobacco Farmers and Manufacturers
    • Other Drugs
    • Other Drugs - Advocacy
    • Other Drugs - In General, II
    • Other Drugs - Policy
    • Other Drugs - Prevention
    • Other Drugs - Treatment
    The Section encourages members interested in health services research, media, advocacy, public policy, prevention and treatment practice to submit abstracts for 2005. Topics of particular interest include:

    · Prevention measures that address all addictive substances and access by minors

    · Models of science-based prevention and coordinated community and legal action

    · Advocacy in all venues

    · Early detection and screening for substance use in various settings

    · Integration of substance use treatment with mental or physical health care

    · Relationship of substance use and health outcomes

    · Special problems of special populations

    · Effective treatment and aftercare in all settings and for all problems

    · International comparisons and impacts

    · Best practices in prevention, screening, treatment and aftercare

    · Evaluations, performance measures, and cost-effectiveness studies

    This year the Program Committee will select the best student abstract submitted, and it’s authors will receive the new Award for Best Student Abstract in November.

    Abstracts are submitted electronically through the APHA Web site, < www.apha.org >. The Web site provides complete instructions on the length and format of abstracts and the information required on authors. Electronic submission is scheduled to open mid-December, 2005. The deadline for submissions is now February 18, 2006.


    Abstracts may be designated “Oral Only”, “Poster Only”, or “No Preference”. Last year, the ATOD Section received about 600 abstracts and were not able to accept all submissions, and that is likely to continue. Many excellent abstracts were not accepted because they were marked “Oral Only” when the Program Committee selected the specific topic for a poster session due to the large number of high quality submissions. Fewer slots are available for oral presentations than for posters, and you are encouraged to designate your abstract “No Preference”. Please give the Program Committee as many options as possible to accept your presentation.

    The ATOD Section ranks abstracts through a multi-tier peer review process. Abstracts are evaluated on importance (does the presentation provide new findings and/or innovative ideas with significant impact on policy, practice or advocacy in the ATOD field?), methodological/project soundness (is the methodology sound, clearly stated, and appropriate to the topic or project? Are the sample and data and/or the population and community recent, representative, unbiased and of adequate size?), and clarity (is the content communicated in a clear, logical and understandable way?), as well as relation to overall Section priorities. Topical sessions are then assembled from high-ranked abstracts. Please note that APHA suggests the program include only one presentation by any individual, and the Section endeavors to abide by this guideline.

    Session Proposals. Proposals for entire sessions (90 minutes in length and at least five presentations) may be submitted for multiple analyses or results from large data sets or projects. They will be ranked in competition with separately submitted abstracts, and the session topic will be weighed against the topics of interest for the Annual Meeting as well as the topics addressed in separately submitted abstracts. The Program Committee reserves the right to break session proposals apart and consider the individual abstracts separately without prior notification to the session organizer.

    Only session proposals which include abstracts for each presentation, an overall session abstract, and have the Confex-assigned ID numbers for abstracts in the session inserted into every abstract, will be considered. The session abstract must include the rationale, moderator, presentation titles, order and length of time for each presentation, and be clearly labeled SESSION ABSTRACT - “your proposed title” on the electronic submission. Each individual abstract should also include the session title and contact information (phone and e-mail) for the person in charge of sessions so we can contact you easily.

    Notification of acceptance or rejection for all abstracts submitted is sent in May by e-mail to the contact person designated in the abstract submission. Presenters are notified of date, time and location of their sessions during the summer. Should you withdraw an accepted abstract, the Program Chair will select a replacement; please do not provide a substitute. Information detailing the ATOD Section’s Preliminary Program and Final Program will be available on the ATOD Section Web site and copies of the Final ATOD Section Program including locations and last-minute changes will be available at the ATOD Section Booth.

    Program Planner Contact Information:
    Barry Bleidt, PhD, PharmD, RPh
    Professor and Associate Dean, Academic Affairs
    Rangel College of Pharmacy Texas A&M University-Kingsville
    PO Box 3037
    Kingsville, TX 78363

    Phone: 361-593-4271
    E-mail:
    Submit Abstract

    Program Planner Contact Information:
    Barry Bleidt, PhD, PharmD
    Professor and Associate Dean, Academic Affairs
    Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center
    MSC 131, 1010 West Avenue B
    Kingsville, TX 78363-8202
    Phone: 361-593-4271
    barry.bleidt@tamuk.edu